Dexlansoprazole Capsule, Delayed Release
Product Images NDC 53401-030

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 53401-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (53401 0030 88)

Label (53401 0030 88)
Dexlansoprazole delayed release 30 mg oral capsules packaging label, showing a 900-capsule count. The label includes storage instructions, manufacturer (Upsher-Smith Laboratories, Inc., Maple Grove, MN), and repackager information (Aphena Pharma, Cookeville, TN). The NDC number visible is 53401-030-88.*
FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical Structure (Dexlansoprazole 01)

Chemical Structure (Dexlansoprazole 01)
Chemical structure of dexlansoprazole, the active ingredient in Dexlansoprazole delayed release capsules 30 mg by Aphena Pharma Solutions. The diagram shows molecular bonds and atomic group arrangements characteristic of dexlansoprazole.*
FDA Label Image

Figure 1 (Dexlansoprazole 02)

Figure 1 (Dexlansoprazole 02)
A pharmacokinetic line graph showing plasma concentration (ng/mL) of dexlansoprazole over time (hours) for 30 mg and 60 mg delayed release capsules. The graph illustrates how plasma levels change from 0 to 24 hours post-dose, with the 60 mg dose yielding higher peak concentrations than the 30 mg dose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.